[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"sports-injuries-in-children\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:sports-injuries-in-children":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,50,73],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":49},"100559060","phase-2-evaluation-of-pain-management-after-surgery-when-using-exparel-in-the-pediatric-population-100559060",false,"NCT06559215","Evaluation of Pain Management After Surgery When Using Exparel in the Pediatric Population","Prospective Evaluation of Post-operative Pain Management Using Exparel in the Pediatric Population","Inclusion Criteria:\n\n* Must be aged 13+ years at time of surgery\n* Must present with injury requiring an isolated MPFL Reconstruction\n* Ability to provide assent, legally appointed representative available to provide informed consent\n\nExclusion Criteria:\n\n* Patient \\\u003C13 years old\n* Requires fracture repair or another non-standardized surgery\n* Any MPFL Reconstruction that requires the use of arthrotomy or a tibial tubercle osteotomy\n* Any lower extremity procedure that is not an isolated MPFL Reconstruction\n* Patient pregnancy\n* Inability to provide assent or legally appointed representative to provide informed consent\n* Prior history of hypersensitivity to Exparel or any local anesthesia\n* BMI ≥ 40","ALL","13 Years","21 Years",{"count":20,"type":21},100,"ESTIMATED","INTERVENTIONAL",[24],"PHASE2","The goal of this randomized clinical trial is to determine if administration of Exparel via local infiltration for medial patellofemoral ligament (MPFL) reconstruction procedures in pediatric orthopaedic sports medicine patients provides significant pain relief and decreased narcotic use. The main questions it aims to answer are:\n\n* Does Exparel significantly reduce Visual Analog Scale (VAS) pain scores and pain levels up to one week postoperatively?\n* Does Exparel significantly decrease narcotic use (number of pills taken) up to one week postoperatively?\n\nResearchers will compare the pain outcomes and narcotic use of patients who receive Exparel and Marcaine via local infiltration to those of patients who receive only Marcaine via local infiltration for their MPFL reconstruction surgery. The goal is to understand if there is a significant difference in patient pain outcomes and narcotic use outside the first 24 hours postoperatively.\n\nParticipants will:\n\n* receive either Exparel + Marcaine intraoperatively or Marcaine only intraoperatively during their MPFL reconstruction surgery\n* receive and complete questionnaires at postoperative days 1, 4, and 7 regarding their pain scores, levels, and outcomes, effective pain treatments, overall pain interference, narcotic use (number of pills taken), and overall pain treatment satisfaction\n* receive and complete secondary outcome measures of functional and psychological outcomes regarding their MPFL reconstruction surgery at postoperative day 1",[27,28,29,30],"Medial Patellofemoral Ligament (MPFL) Reconstruction","Sports Injuries in Children","Analgesia","Pain, Postoperative",[32,33,34,35,36],"Narcotic use","Postoperative pain management","MPFL reconstruction","Visual Analog Scale (VAS) pain scores","Multimodal pain management protocol","RECRUITING","2026-03-05",{"date":40,"type":41},"2026-03-09","ACTUAL",{"date":43,"type":41},"2025-12-01",{"date":45,"type":21},"2028-09",{"name":47,"class":48},"Texas Scottish Rite Hospital for Children","OTHER",1,{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":4,"eligibilityCriteria":56,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":57,"targetDuration":4,"studyType":22,"phases":59,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":72,"locationsCount":49},"100559054","phase-2-evaluation-of-pain-management-after-surgery-when-using-nerve-blocks-in-the-pediatric-population-100559054","NCT06559137","Evaluation of Pain Management After Surgery When Using Nerve Blocks in the Pediatric Population","Prospective Evaluation of Post-operative Pain Management Using Peripheral Nerve Blocks in the Pediatric Population","Inclusion Criteria:\n\n* Must be aged 13+ years at time of surgery\n* Must present with injury requiring an ACLR procedure with a Bone Patellar Tendon Bone or Quadriceps graft\n* Ability to provide assent, legally appointed representative available to provide informed consent\n\nExclusion Criteria:\n\n* Patient \\\u003C13 years old\n* Requires fracture repair or another non-standardized surgery\n* Any ACLR that requires the use of a graft type other than Bone Patellar Tendon Bone or Quadriceps tendon\n* Any lower extremity procedure that is not primarily an ACLR\n* Patient pregnancy\n* Inability to provide assent or legally appointed representative to provide informed consent\n* Prior history of hypersensitivity to Ropivacaine or any local anesthesia\n* BMI ≥ 40",{"count":58,"type":21},160,[24],"The goal of this randomized clinical trial is to determine if single-shot ropivacaine peripheral nerve blocks (PNB - perineural injections) for anterior cruciate ligament (ACL) reconstruction procedures in pediatric orthopaedic sports medicine patients provides significant pain relief and decreased narcotic use. The main questions it aims to answer are:\n\n* Does ropivacaine significantly reduce Visual Analog Scale (VAS) pain scores and pain levels up to one week postoperatively?\n* Does ropivacaine significantly decrease narcotic use (number of pills taken) up to one week postoperatively?\n\nResearchers will compare the pain outcomes and narcotic use of participants who receive a single-shot ropivacaine peripheral nerve block to those of participants who do not receive a single-shot ropivacaine peripheral nerve block for their ACL reconstruction surgery. The goal is to understand if there is a significant difference in participant pain outcomes and narcotic use outside the first 24 hours postoperatively.\n\nParticipants will:\n\n* receive either a single-shot ropivacaine peripheral nerve block intraoperatively or no peripheral nerve block during their ACL Quadriceps tendon graft or bone patellar tendon bone graft reconstruction surgery.\n* receive and complete questionnaires at postoperative days 1, 4, and 7 regarding their pain scores, levels, and outcomes, effective pain treatments, overall pain interference, narcotic use (number of pills taken), and overall pain treatment satisfaction\n* receive and complete secondary outcome measures of functional and psychological outcomes regarding their ACL reconstruction surgery at postoperative day 1",[62,28,29,30],"Anterior Cruciate Ligament (ACL) Tear",[32,33,64,35,36],"ACL reconstruction","NOT_YET_RECRUITING","2025-09-09",{"date":68,"type":41},"2025-09-16",{"date":70,"type":21},"2025-09",{"date":45,"type":21},{"name":47,"class":48},{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":81,"enrollmentInfo":82,"targetDuration":4,"studyType":22,"phases":84,"briefSummary":86,"conditions":87,"keywords":89,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":95,"leadSponsor":97,"locationsCount":49},"100600573","cervico-vestibular-home-exercise-program-feasibility-100600573","NCT07099248","Cervico-vestibular Home Exercise Program Feasibility","Feasibility and Acceptability of a Cervico-vestibular Home Exercise Program Following Concussion in Children","Concussion HEP","Inclusion Criteria:\n\n1. Patients \\\u003C18 years old\n2. Presenting to clinic ≤1 month after injury\n3. Diagnosed with a concussion at their clinic visit\n4. Have a total symptom score of 3 or more on the PCSI\n5. Visual acuity\u002Fhearing adequate for testing\n6. Parent\u002Fpatient must be fluent in English\n7. Ability to provide assent, Legally Appointed Representative available to provide informed consent\n\nExclusion Criteria:\n\n1. Patients ≥18 years old\n2. Moderate and severe TBI\n3. History of seizures\n4. History of \\>3 prior concussions\n5. History of chronic headaches\u002Fmigraines\n6. Presenting to clinic \\>1 month after injury","17 Years",{"count":83,"type":21},30,[85],"NA","The purpose of this pilot study is to:\n\n1. Determine the feasibility of adherence to completing the home cervico-vestibular exercise program following concussion.\n2. Investigate the acceptability of the cervico-vestibular home exercise program.\n3. Investigate the impact of the cervico-vestibular home exercise program on symptom reduction, return to play, and return to learn\n4. Analyze the timing at which a home exercise program is typically prescribed.\n\nParticipants will be asked to do and keep track of exercises made to help in their concussion recovery over a two-week period. Participants will come back to see their doctor and complete surveys about how easy the exercises were to do and if they liked them.",[88,28],"Concussion",[88,90],"Home Exercise Program","2025-07-25",{"date":93,"type":41},"2025-08-01",{"date":70,"type":21},{"date":96,"type":21},"2026-08",{"name":47,"class":48}]